Alzheimer's Disease

Displaying 1 - 6 of 6


Landman awarded $2.6 million grant to improve Alzheimer’s patient management

An electrical and computer engineering professor has received a $2.6 million NIH grant to improve the understanding of structural changes in the brains of people who have Alzheimer’s Disease.


Jerri Rook is awarded the Alzheimer’s Drug Discovery Foundation’s prestigious Melvin R. Goodes prize

Vanderbilt University Assistant Professor of Pharmacology Jerri Rook has been recognized with the 2020 Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery. Presented by the Alzheimer’s Drug Discovery Foundation, the prize recognizes leading researchers who are developing treatments for Alzheimer’s disease and related dementias.


Study examines HIV drug’s potential to treat Alzheimer’s

A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease, and Vanderbilt University biochemist F. Peter Guengerich, PhD, is aiding efforts to make this approach to improving memory and cognitive function even better.


Using a mapping technique to reassess prior Alzheimer’s studies finds ‘powerful,’ improved reproducibility

A neural mapping approach that pegs results from more than two dozen previous Alzheimer’s studies found that reproducibility improves when trying to isolate symptoms to a brain network rather than a single area of the brain.